Abstract:ABSTRACT Bacteriophages have (re)gained popularity as an adjunct antibacterial therapy. On top of the self-amplifying character of phages, their titer can be influenced by several factors which could lead to reduced titers after preparation and storage. The stability of phage preparations, used for the treatment of chronic rhinosinusitis (CRS), sepsis, pulmonary, and musculoskeletal infections, was investigated. Staphylococcus aureus phage ISP and Pseudomonas aeruginosa phages PNM, 14-1 and PT07 were evaluated. These phages were magistrally prepared by diluting active pharmaceutical products and storing them in different polypropylene/polycarbonate syringes at 4°C. Titers were monitored for 7–21 days using the double-agar overlay method. For 7 days, titers remained stable. Afterwards, the phage titer reduced for all phages with an average reduction of 0.78 log ( P < 0.0001) plaque-forming units (PFUs)/mL after 14 days and 1 log PFU/mL after 21 days ( P < 0.0001). PT07 titers dropped below the predefined threshold after 2 days in polycarbonate syringes. In addition, the stability after irrigation using a nasal douche (CRS) and infusion through a catheter (sepsis) was assessed. No changes were observed after using these devices with a mean change in titer of −0.07 log PFU/mL ( P = 0.9062) and −0.03 log PFU/mL ( P = 0.7350), respectively. In conclusion, a decreased titer after storage of a phage solution can lead to administration of subtherapeutic concentrations. In our experiments, we demonstrated that liquid phage solutions can be stored in syringes at 4°C for 5–7 days. PT07 appeared to be less stable, especially in polycarbonate syringes. Irrigation using a nasal douche or infusion through a catheter does not impact phage titer. IMPORTANCE As antimicrobial resistance becomes more prevalent, the application of (bacterio)phage therapy as an alternative treatment for difficult-to-treat infections is (re)gaining popularity. Over the past decade, numerous promising case reports and series have been published demonstrating the therapeutic potential of phage therapy. However, important questions remain regarding the optimal treatment protocol and, unlike for medicinal products, there are currently no predefined quality standards for the stability of phage preparations. Phage titers can be influenced by several factors which could lead to reduced titers after preparation and storage and, ultimately, subtherapeutic applications. Determining the stability of different phages in different recipients according to the route of administration is therefore one of the first important steps in establishing a standardized protocol for phage therapy.

Characterization of transfusion‐relevant bacteria reference strains in a lyophilized format

Proliferation of psychrotrophic bacteria in cold-stored platelet concentrates

Assessment of bacterial growth in leukoreduced cold-stored whole blood supports overnight hold at room temperature prior to filtration: A pilot study

Development of an In-House Rapid Antimicrobial Susceptibility Testing Protocol for Positive Blood Culture and Its Implementation in Routine Microbiology Laboratories

Growth and Distribution of Bacteria in Contaminated Whole Blood and Derived Blood Components

The international experience of bacterial screen testing of platelet components with automated microbial detection systems: An update

The impact of red blood cell manufacturing variables on bacterial growth dynamics: a pilot study

The use of a chemiluminescence‐linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell‐reduced and nonreduced platelets

Detection of bacteria in platelet concentrates prepared from spiked single donations using cultural and molecular genetic methods

Bacterial Detection of Platelets: Current Problems and Possible Resolutions

Development of blood transfusion product pathogen reduction treatments: A review of methods, current applications and demands

Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction

Operational feasibility of routine bacterial monitoring of platelets

Comparison of an automated DNA extraction and 16S rDNA real time PCR/sequencing diagnostic method using optimized reagents with culture during a 15-month study using specimens from sterile body sites

Affordable blood culture systems from China: in vitro evaluation for use in resource-limited settings

Routine bacterial screening of platelet concentrates by flow cytometry and its impact on product safety and supply

Three Different Bacterial Detection Systems for Platelet Concentrates under Inter-Laboratory Conditions.

Impact of Clinical Practice Guidelines on the Clinical Microbiology Laboratory When Using Automated Blood Culture Systems for Bacterial Contamination Screening of Apheresis Platelet Products

Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system

Bacterial species in cord blood and their significance in the context of clinical use

Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections